Guo-Hua Fong

Education

Zhejiang University, 1982, BSc, Biology; University of Illinois at Urbana-Champaign, 1988, PhD, Biochemistry

Professional Area

Developmental Biology of the Vascular System; Angiogenesis in healthy and diseased retinal tissues; Oxygen sensing and hypoxia signaling in the vascular system; Genetic manipulation of the mouse genome

Citation

Internationally recognized for contributions in fields of angiogenesis; discovery of vascular endothelial growth factor receptor-1 as a suppressor for angiogenesis paved way for pharmaceutical industry to develop Aflibercept, an anti-angiogenesis drug approved by FDA for treating metastatic colorectal cancer and age-related macular degeneration.